Chinese researchers at Westlake University have developed a handheld device that detects early-stage cancer biomarkers from a single drop of blood with unprecedented accuracy.
Westlake University (Nature Photonics) developed a handheld cancer-screening device from a blood drop, 10,000x more accurate than conventional methods. Shrinking a refrigerator-sized system to pocket scale opens point-of-care and remote diagnostics markets.
The device is 10,000 times more accurate than conventional methods
May 25, 2026
01:17 pm
What's the storyA team of researchers from Westlake University, Hangzhou, has developed a handheld device that could soon be used to screen for early-stage cancer from a single drop of blood.
The innovative technology, which was mentioned in the journal Nature Photonics, is said to be 10,000 times more accurate than conventional methods.
The new system is about 10,000 times more sensitive than traditional methods at detecting early-stage lung cancer.
Prototype achieves diagnosis accuracy of up to 95 per cent, researchers say
Deadly ‘king of cancers’ is marked by late diagnosis and rapid metastasis. New genomic tool may pave way to early and tailored…
Cambridge scientists hunting tell-tale killer ‘zombie’ cells that signal early lung cancer have developed a world-first urine…
Una nuova tecnologia potrebbe consentire lo screening del sangue per il tumore polmonare in una fase in cui la massa tumorale è…
Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank…
Urine test could help detect lung cancer years before symptoms occur
